Lipopolysaccharide/NN
is/VBZ
a/DT
potent/JJ
monocyte/macrophage-specific/JJ
stimulator/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
expression/NN
./.

Lipopolysaccharide/NN
(/(
LPS/NN
)/)
potently/RB
stimulates/VBZ
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1-long/JJ
terminal/JJ
repeat/NN
(/(
HIV-1-LTR/NN
)/)
CAT/NN
constructs/NNS
transfected/VBN
into/IN
monocyte/macrophage-like/JJ
cell/NN
lines/NNS
but/CC
not/RB
a/DT
T/NN
cell/NN
line/NN
./.
=====
This/DT
effect/NN
appears/VBZ
to/TO
be/VB
mediated/VBN
through/IN
the/DT
induction/NN
of/IN
nuclear/JJ
factor/NN
kappa/NN
B/NN
(/(
NF-kappa/NN
B/NN
)/)
./.
=====
Electrophoretic/JJ
mobility/NN
shift/NN
assays/NNS
demonstrate/VBP
that/IN
LPS/NN
induces/VBZ
a/DT
DNA/NN
binding/NN
activity/NN
indistinguishable/JJ
from/IN
NF-kappa/NN
B/NN
in/IN
U937/NN
and/CC
THP-1/NN
cells/NNS
./.
=====
LPS/NN
is/VBZ
also/RB
shown/VBN
to/TO
dramatically/RB
increase/VB
HIV-1/NN
production/NN
from/IN
a/DT
chronically/RB
infected/JJ
monocyte/macrophage-like/JJ
cloned/VBN
cell/NN
line/NN
,/,
U1/NN
,/,
which/WDT
produces/VBZ
very/RB
low/JJ
levels/NNS
of/IN
HIV-1/NN
at/IN
baseline/NN
./.
=====
The/DT
stimulation/NN
of/IN
viral/JJ
production/NN
from/IN
this/DT
cell/NN
line/NN
occurs/VBZ
only/RB
if/IN
these/DT
cells/NNS
are/VBP
treated/VBN
with/IN
granulocyte/macrophage/JJ
colony-stimulating/JJ
factor/NN
(/(
GM-CSF/NN
)/)
before/IN
treatment/NN
with/IN
LPS/NN
./.
=====
This/DT
stimulation/NN
of/IN
HIV-1/NN
production/NN
is/VBZ
correlated/VBN
with/IN
an/DT
increase/NN
in/IN
the/DT
level/NN
of/IN
HIV-1/NN
RNA/NN
and/CC
and/CC
activation/NN
of/IN
NF-kappa/NN
B/NN
./.
=====
LPS/NN
is/VBZ
not/RB
able/JJ
to/TO
induce/VB
HIV-1/NN
production/NN
in/IN
a/DT
cloned/VBN
T/NN
cell/NN
line/NN
./.
=====
The/DT
effect/NN
of/IN
LPS/NN
on/IN
HIV-1/NN
replication/NN
occurs/VBZ
at/IN
picogram/NN
per/IN
milliliter/NN
concentrations/NNS
and/CC
may/MD
be/VB
clinically/RB
significant/JJ
in/IN
understanding/VBG
the/DT
variability/NN
of/IN
the/DT
natural/JJ
history/NN
of/IN
HIV-1/NN
infection/NN
./.